Certara

IPO

Accelerating medicines to patients with biosimulation, technology and services

Certara is a biotech company in Radnor, United States, founded in 2008. It has raised $1.3B across 2 rounds, most recently a $449.0M Private Equity in December 2022.

Employees
1001–5000
Founded
2008
Business Model
B2B
Total Funding
$1.3B
Last Round
$449.0M Private EquityDec 2022
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. to use credits for reveals, or explore the API.

About

Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies.

Funding & Exit History

Data from Indexed.vcUpdated
Private EquityPrivate EquityDec 2022
$449.0M

2 more events

  • IPO2020
  • Private Equity20172 investors

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Backend ×1
  • Cloud/Infrastructure ×1
  • CRM & Sales ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Acquisitions

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Certara on Indexed.vc
<a href="https://indexed.vc/companies/certara"><img src="https://indexed.vc/api/badge/company/certara" alt="Certara on Indexed.vc" width="260" height="76" /></a>